title: Tigecycline for severe Clostridium difficile infection.
abstract: Limited data suggest that tigecycline may be of value in the treatment of Clostridiumdifficile infection. We reviewed our experience using tigecycline to treat severe c. difficile and compared outcomes to similarly ill patients who did not receive tigecycline. We found no difference between the groups. Further study is needed before tigecycline can be recommended for use in severe C. difficile infection.
authors: Orlando Health, Orlando, Florida, USA.
authors: Ashley
authors: A
authors: Thomas
authors: Orlando Health, Orlando, Florida, USA.
authors: Farhan
authors: F
authors: Khan
authors: University of Central Florida, Orlando, Florida, USA.
authors: Nizam
authors: N
authors: Uddin
authors: Orlando Health, Orlando, Florida, USA; Florida State University, Orlando Health, 21 W. Columbia St, Ste. 102, Orlando, FL32806, USA. Electronic address: Mark.Wallace@orlandohealth.com.
authors: Mark R
authors: MR
authors: Wallace
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D003015:Clostridium Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D008911:Minocycline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078304:Tigecycline
chemical_list: D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline
keywords: Clostridium difficile; Colitis; Tigecycline